Metraipolis › archive › dc_2bebd44ec284

Bilirubin in Parkinson's disease: pathogenic mechanisms and therapeutic potentials — Europe PMC PMID:42131706

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42131706
DOI
10.3389/fnins.2026.1806875
License (as archived)
solo-consultazione
Archived
2026-11-03T01:51:23.989Z
SHA-256 of the archived text
c84a21f45f4db3d537582e7a432b80c00c2cbec3d1f24cb848fb8dfa2af20e80
Stable URL of this page
https://metraipolis.com/documento/dc_2bebd44ec284

How to cite

Bilirubin in Parkinson's disease: pathogenic mechanisms and therapeutic potentials — Europe PMC PMID:42131706 — Europe PMC (en), https://europepmc.org/article/MED/42131706 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2bebd44ec284 (Metraipolis archive dc_2bebd44ec284, sha256 c84a21f45f4db3d537582e7a432b80c00c2cbec3d1f24cb848fb8dfa2af20e80)
BibTeX
@misc{dc2bebd44ec284,
  title = {Bilirubin in Parkinson's disease: pathogenic mechanisms and therapeutic potentials — Europe PMC PMID:42131706},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42131706},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2bebd44ec284; sha256 c84a21f45f4db3d537582e7a432b80c00c2cbec3d1f24cb848fb8dfa2af20e80},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42131706. Agents can read the archived copy with the MCP tool read_document.